Company / Operating Cash Flow
Medtronic Operating Cash Flow History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$6.8B
FY2026
5-year range
$6.0B / $7.2B
FY2022-FY2026
Trend
+12.4%
vs FY2025
Sector context
#7 of 164
Health Care
What the data says
Among 164 Health Care companies, Medtronic is in the top 4% for operating cash flow. Operating Cash Flow has fluctuated over the past 10 years, ranging from $4.7B in FY2017 to $7.2B in FY2022.
Based on SEC 10-K filings.
$6.8B in FY2026 with a 5-year CAGR of -0.6%. Top quartile in the Health Care sector.
Declined from $7.0B to $6.8B over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +2.8%
- 5-Year CAGR
- -0.6%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 164This company $6.8B Sector average $1.0B
▼
+550.2% above sector average
Key checks
Key Insights
- 5-year CAGR of -0.6%, indicating a declining trend.
- In FY2026, operating cash flow increased 12.4% year-over-year.
- Ranks #7 out of 164 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2022.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $6.8B | +12.4% |
| FY2025 | $6.0B | -14.3% |
| FY2024 | $7.0B | +12.9% |
| FY2023 | $6.2B | -13.7% |
| FY2022 | $7.2B | +3.2% |
| FY2021 | $7.0B | +12.3% |
| FY2020 | $6.2B | -13.7% |
| FY2019 | $7.2B | +3.2% |
| FY2018 | $7.0B | +49.6% |
| FY2017 | $4.7B | -31.9% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026